Log In
Print
BCIQ
Print
Print this Print this
 

pracinostat (formerly SB939)

  Manage Alerts
Collapse Summary General Information
Company MEI Pharma Inc.
DescriptionClass I, II and IV oral histone deacetylase (HDAC) inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today